210 related articles for article (PubMed ID: 30517741)
21. Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PIH) determines the efflux of iron complexes and toxicity in K562 cells.
Buss JL; Arduini E; Shephard KC; Ponka P
Biochem Pharmacol; 2003 Feb; 65(3):349-60. PubMed ID: 12527328
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor alpha controls hepatic heme biosynthesis through ALAS1.
Degenhardt T; Väisänen S; Rakhshandehroo M; Kersten S; Carlberg C
J Mol Biol; 2009 May; 388(2):225-38. PubMed ID: 19289130
[TBL] [Abstract][Full Text] [Related]
23. Pyridoxal isonicotinoyl hydrazone inhibits iron-induced ascorbate oxidation and ascorbyl radical formation.
Maurício AQ; Lopes GK; Gomes CS; Oliveira RG; Alonso A; Hermes-Lima M
Biochim Biophys Acta; 2003 Mar; 1620(1-3):15-24. PubMed ID: 12595068
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs.
Buss JL; Neuzil J; Ponka P
Arch Biochem Biophys; 2004 Jan; 421(1):1-9. PubMed ID: 14678779
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic formation of zinc-protoporphyrin by rat liver and its potential effect on hepatic heme metabolism.
Bloomer JR; Reuter RJ; Morton KO; Wehner JM
Gastroenterology; 1983 Sep; 85(3):663-8. PubMed ID: 6873612
[TBL] [Abstract][Full Text] [Related]
26. Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.
Hermes-Lima M; Gonçalves MS; Andrade RG
Mol Cell Biochem; 2001 Dec; 228(1-2):73-82. PubMed ID: 11855743
[TBL] [Abstract][Full Text] [Related]
27. Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
Barman-Aksözen J; Halloy F; Iyer PS; Schümperli D; Minder AE; Hall J; Minder EI; Schneider-Yin X
Mol Genet Metab; 2019 Nov; 128(3):304-308. PubMed ID: 31076252
[TBL] [Abstract][Full Text] [Related]
28. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) protects plasmid pUC-18 DNA against *OH-mediated strand breaks.
Hermes-Lima M; Nagy E; Ponka P; Schulman HM
Free Radic Biol Med; 1998 Nov; 25(8):875-80. PubMed ID: 9840731
[TBL] [Abstract][Full Text] [Related]
29. Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes.
Ponka P; Richardson D; Baker E; Schulman HM; Edward JT
Biochim Biophys Acta; 1988 Oct; 967(1):122-9. PubMed ID: 3167093
[TBL] [Abstract][Full Text] [Related]
30. Effect of pyridoxal isonicotinoyl hydrazone and analogs on iron metabolism in hepatocytes and macrophages in culture.
Richardson D; Baker E; Ponka P; Wilairat P; Vitolo ML; Webb J
Birth Defects Orig Artic Ser; 1988; 23(5B):81-8. PubMed ID: 3390577
[No Abstract] [Full Text] [Related]
31. In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Barman-Aksözen J; Minder EI; Schubiger C; Biolcati G; Schneider-Yin X
Blood Cells Mol Dis; 2015 Jan; 54(1):71-7. PubMed ID: 25179834
[TBL] [Abstract][Full Text] [Related]
32. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
[TBL] [Abstract][Full Text] [Related]
33. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron.
Chen YL; Kong X; Xie Y; Hider RC
J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026
[TBL] [Abstract][Full Text] [Related]
34. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
Richardson DR; Ponka P
J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
[TBL] [Abstract][Full Text] [Related]
35. Biliary iron excretion in rats following treatment with analogs of pyridoxal isonicotinoyl hydrazone.
Bláha K; Cikrt M; Nerudová J; Ponka HF
Blood; 1998 Jun; 91(11):4368-72. PubMed ID: 9596686
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of transferrin and gallium-pyridoxal isonicotinoyl hydrazone as potential therapeutic agents to overcome lymphoid leukemic cell resistance to gallium nitrate.
Chitambar CR; Boon P; Wereley JP
Clin Cancer Res; 1996 Jun; 2(6):1009-15. PubMed ID: 9816262
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.
Zheng J; Shan Y; Lambrecht RW; Donohue SE; Bonkovsky HL
Mol Cell Biochem; 2008 Dec; 319(1-2):153-61. PubMed ID: 18719978
[TBL] [Abstract][Full Text] [Related]
38. Aging-related changes in the iron status of skeletal muscle.
DeRuisseau KC; Park YM; DeRuisseau LR; Cowley PM; Fazen CH; Doyle RP
Exp Gerontol; 2013 Nov; 48(11):1294-302. PubMed ID: 23994517
[TBL] [Abstract][Full Text] [Related]
39. Porcine ferrochelatase: the relationship between iron-removal reaction and the conversion of heme to Zn-protoporphyrin.
Chau TT; Ishigaki M; Kataoka T; Taketani S
Biosci Biotechnol Biochem; 2010; 74(7):1415-20. PubMed ID: 20622448
[TBL] [Abstract][Full Text] [Related]
40. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and its analogues prevent damage to 2-deoxyribose mediated by ferric iron plus ascorbate.
Hermes-Lima M; Ponka P; Schulman HM
Biochim Biophys Acta; 2000 Oct; 1523(2-3):154-60. PubMed ID: 11042379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]